Arbutus Biopharma Corp. buy me8
Start price
01.12.21
/
0%
€3.96
Target price
01.12.22
€6.00
Performance (%)
-2.70%
End price
11.12.21
€3.85
Summary
This prediction ended on 11.12.21 with a price of €3.85. With a performance of -2.70%, the BUY prediction by me8 finished with a loss. This prediction was marked as speculative and is excluded from me8's performance statistics.Performance without dividends (%)
| Name | 1w | 1m | 1y |
|---|---|---|---|
| Arbutus Biopharma Corp. | -0.844% | -0.844% | 80.266% |
| iShares Core DAX® | -0.116% | 1.953% | 14.155% |
| iShares Nasdaq 100 | -2.733% | -1.273% | 31.828% |
| iShares Nikkei 225® | -1.721% | 3.263% | 12.922% |
| iShares S&P 500 | -1.527% | 0.194% | 27.117% |
According to me8 what are the pros and cons of Arbutus Biopharma Corp. for the foreseeable future?
Pros
Could be worthwhile Investment >10% per year
Innovative
Good culture
Cons
Below average Management
Comments by me8 for this prediction
In the thread Arbutus Biopharma Corp. diskutieren
Buy Arbutus Biopharma Corp.
Kursziel gesetzt auf 6,0
In the thread Trading Arbutus Biopharma Corp.
Einschätzung wurde nach dem Ende von Catch the Monkey automatisch beendet.